Cancellation of state registration. Doxazosin Sandoz®

February 15, 2017
Active substances:
Trade names:
ICD-10:
IX.I10-I15.I10    Essential [primary] hypertension
XIV.N40-N51.N40    Hyperplasia of the prostate
Doxazosin, alpha1-adrenoblocker, arterial hypertension, prostatic hyperplasia

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state registermedicinal products for medical use of the medicinal product (registration certificate LSR-008201/09 dated 16.10.2009 issued Sandoz d., Slovenia):

Doxazosin Sandoz® (trade name of the drug)

Doxazosin (international non-patented or batch or chemical name)

pills, 1 mg, 2 mg, 4 mg (dosage form, dosage)

Salyutas Pharma GmbH, Germany (name and address of the manufacturer of the medicinal product).